Neuroscience
Amyloid-beta levels are significantly reduced and spatial memory defects are rescued in a novel neuroserpin-deficient Alzheimer's disease transgenic mouse model
J Neurochem. 2011 Sep; 118(5): 928-38
Authors: Fabbro S, Schaller K, Seeds NW
Abstract
Amyloid-beta (Aβ) plaques are a hallmark of Alzheimer's disease. Several proteases including plasmin are thought to promote proteolytic cleavage and clearance of Aβ from brain. The activity of both plasmin and tissue plasminogen activator are reduced in Alzheimer's disease brain, while the tissue plasminogen activator inhibitor neuroserpin is up-regulated. Here, the relationship of tissue plasminogen activator and neuroserpin to Aβ levels is explored in mouse models. Aβ(1-42) peptide injected into the frontal cortex of tissue plasminogen activator knockout mice is slow to disappear compared to wildtype mice, whereas neuroserpin knockout mice show a rapid clearance of Aβ(1-42). The relationship of neuroserpin and tissue plasminogen activator to Aβ plaque formation was studied further by knocking-out neuroserpin in the human amyloid precursor protein-J20 transgenic mouse. Compared to the J20-transgenic mouse, the neuroserpin-deficient J20-transgenic mice have a dramatic reduction of Aβ peptides, fewer and smaller plaques, and more active tissue plasminogen activator associated with plaques. Furthermore, neuroserpin-deficient J20-transgenic mice have near normal performances in the Morris water maze, in contrast to the spatial memory defects seen in J20-transgenic mice. These results support the concept that neuroserpin inhibition of tissue plasminogen activator plays an important role both in the accumulation of brain amyloid plaques and loss of cognitive abilities.
PMID: 21689108 [PubMed - indexed for MEDLINE]
- Neuropsychology Abstract Of The Day: Samp8
Hippocampal neuron loss is correlated with cognitive deficits in SAMP8 mice. Neurol Sci. 2012 Aug 8; Authors: Li G, Cheng H, Zhang X, Shang X, Xie H, Zhang X, Yu J, Han JAbstractThe objective of this study is to examine whether neuron loss occurs in SAMP8...
- Alzheimer's: Impaired Beta-amyloid Clearance
From the NIH: Impaired clearance, not overproduction of toxic proteins, may underlie Alzheimer’s disease 09 December 2010 In Alzheimer's disease, a protein fragment called beta-amyloid accumulates at abnormally high levels in the brain. Now researchers...
- Neuropsychology Abstract Of The Day: Sorl1 And Alzheimer Disease
Ekaterina Rogaeva, Yan Meng, Joseph H Lee, Yongjun Gu, Toshitaka Kawarai, et al. (2007). The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nature Genetics, Published online: 14 January 2007; | doi:10.1038/ng1943....
- Knockout Mice Are The Bomb!
From an NIH press release from earlier today: NIH Launches Knockout Mouse Project Genome-Wide Public Resource Will Provide New Mouse Models for Understanding Human Disease The National Institutes of Health (NIH) today awarded a set...
- Af267b And Alzheimer Disease
From medicalnewstoday.com:Experimental Drug Reverses Key Cognitive Deficits, Pathology In Alzheimer's Main Category: Alzheimer's News Article Date: 04 Mar 2006 - 13:00pm (UK) A new drug that enhances the activity of a key brain cell receptor...
Neuroscience
Neuropsychology Abstract of the Day: Alzheimer's Disease
Amyloid-beta levels are significantly reduced and spatial memory defects are rescued in a novel neuroserpin-deficient Alzheimer's disease transgenic mouse model
J Neurochem. 2011 Sep; 118(5): 928-38
Authors: Fabbro S, Schaller K, Seeds NW
Abstract
Amyloid-beta (Aβ) plaques are a hallmark of Alzheimer's disease. Several proteases including plasmin are thought to promote proteolytic cleavage and clearance of Aβ from brain. The activity of both plasmin and tissue plasminogen activator are reduced in Alzheimer's disease brain, while the tissue plasminogen activator inhibitor neuroserpin is up-regulated. Here, the relationship of tissue plasminogen activator and neuroserpin to Aβ levels is explored in mouse models. Aβ(1-42) peptide injected into the frontal cortex of tissue plasminogen activator knockout mice is slow to disappear compared to wildtype mice, whereas neuroserpin knockout mice show a rapid clearance of Aβ(1-42). The relationship of neuroserpin and tissue plasminogen activator to Aβ plaque formation was studied further by knocking-out neuroserpin in the human amyloid precursor protein-J20 transgenic mouse. Compared to the J20-transgenic mouse, the neuroserpin-deficient J20-transgenic mice have a dramatic reduction of Aβ peptides, fewer and smaller plaques, and more active tissue plasminogen activator associated with plaques. Furthermore, neuroserpin-deficient J20-transgenic mice have near normal performances in the Morris water maze, in contrast to the spatial memory defects seen in J20-transgenic mice. These results support the concept that neuroserpin inhibition of tissue plasminogen activator plays an important role both in the accumulation of brain amyloid plaques and loss of cognitive abilities.
PMID: 21689108 [PubMed - indexed for MEDLINE]
- Neuropsychology Abstract Of The Day: Samp8
Hippocampal neuron loss is correlated with cognitive deficits in SAMP8 mice. Neurol Sci. 2012 Aug 8; Authors: Li G, Cheng H, Zhang X, Shang X, Xie H, Zhang X, Yu J, Han JAbstractThe objective of this study is to examine whether neuron loss occurs in SAMP8...
- Alzheimer's: Impaired Beta-amyloid Clearance
From the NIH: Impaired clearance, not overproduction of toxic proteins, may underlie Alzheimer’s disease 09 December 2010 In Alzheimer's disease, a protein fragment called beta-amyloid accumulates at abnormally high levels in the brain. Now researchers...
- Neuropsychology Abstract Of The Day: Sorl1 And Alzheimer Disease
Ekaterina Rogaeva, Yan Meng, Joseph H Lee, Yongjun Gu, Toshitaka Kawarai, et al. (2007). The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nature Genetics, Published online: 14 January 2007; | doi:10.1038/ng1943....
- Knockout Mice Are The Bomb!
From an NIH press release from earlier today: NIH Launches Knockout Mouse Project Genome-Wide Public Resource Will Provide New Mouse Models for Understanding Human Disease The National Institutes of Health (NIH) today awarded a set...
- Af267b And Alzheimer Disease
From medicalnewstoday.com:Experimental Drug Reverses Key Cognitive Deficits, Pathology In Alzheimer's Main Category: Alzheimer's News Article Date: 04 Mar 2006 - 13:00pm (UK) A new drug that enhances the activity of a key brain cell receptor...